[HTML][HTML] Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

M Peghin, A Palese, M Venturini, M De Martino… - Clinical Microbiology …, 2021 - Elsevier
Objectives To assess the prevalence of and factors associated with post-coronavirus
disease 2019 (COVID-19) syndrome 6 months after the onset. Methods A bidirectional …

[HTML][HTML] Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients

M Peghin, M De Martino, A Palese, V Gerussi… - Clinical Microbiology …, 2022 - Elsevier
Objectives This study aimed to describe the impact of vaccination and the role of humoral
responses on post–COVID-19 syndrome 1 year after the onset of SARS coronavirus type 2 …

[HTML][HTML] Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: the LONG-COVID-EXP-CM multicenter …

C Fernández-de-Las-Peñas, OJ Pellicer-Valero… - International Journal of …, 2022 - Elsevier
Objective This multicenter study investigated clinical risk factors associated with the number
of long-term symptoms after COVID. Methods Clinical features, symptoms at hospital …

Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study

O Moreno-Pérez, E Merino, JM Leon-Ramirez… - Journal of Infection, 2021 - Elsevier
Objectives This study aims to analyze the incidence of Post-acute COVID-19 syndrome
(PCS) and its components, and to evaluate the acute infection phase associated risk factors …

Post-COVID-19 syndrome: nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in Nord Franche-Comté Hospital …

S Zayet, H Zahra, PY Royer, C Tipirdamaz, J Mercier… - Microorganisms, 2021 - mdpi.com
(1) Background. Post-COVID-19 syndrome is defined as the persistence of symptoms after
confirmed SARS-CoV-2 infection.(2) Methods. ANOSVID is an observational retrospective …

[HTML][HTML] Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study

J García-Abellán, S Padilla… - Journal of clinical …, 2021 - Springer
Background The relationship of host immune response and viral replication with health
outcomes in patients with COVID-19 remains to be defined. We aimed to characterize the …

[HTML][HTML] SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons

N Wellinghausen, D Plonné, M Voss, R Ivanova… - Journal of Clinical …, 2020 - Elsevier
Commercially available immunoassays have been developed for sensitive and specific
detection of antibodies against SARS-CoV-2. While a fast and reliable IgG response has …

Kinetics of SARS-CoV-2 specific and neutralizing antibodies over seven months after symptom onset in COVID-19 patients

L Zhu, X Xu, B Zhu, X Guo, K Xu, C Song… - Microbiology …, 2021 - Am Soc Microbiol
To assess the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) antibodies produced by natural infection and describe the serological characteristics over …

Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19

X Jing, M Xu, D Song, T Yue, Y Wang, P Zhang… - Immunity & …, 2022 - Springer
Background COVID-19 patients may experience “cytokine storm” when human immune
system produces excessive cytokines/chemokines. However, it remains unclear whether …

Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders

E Marklund, S Leach, H Axelsson, K Nyström… - PloS one, 2020 - journals.plos.org
Background To accurately interpret COVID-19 seroprevalence surveys, knowledge of serum-
IgG responses to SARS-CoV-2 with a better understanding of patients who do not …